Neflamapimod
EIP22-NFD-505
Phase 2 small_molecule active
Quick answer
Neflamapimod for Dementia with Lewy Bodies (DLB) is a Phase 2 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Dementia with Lewy Bodies (DLB)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active